The global post-traumatic stress disorder treatment market was valued at $15,976.64 million in 2021 and is projected to reach $26,060.75 million by 2031, registering a CAGR of 4.9% from 2022 to 2031. Post-traumatic stress disorder is a serious condition related to mental health. It is caused due to life-threatening events, recurrent anxiety, sex abuse & internal reminder of traumatic events. The symptoms of the disorder include flashbacks, nightmares, swings of mood, changes in physical activities & uncontrollable thoughts about the incident that may cause a stressed condition for the patient. Post-Traumatic Stress Disorder (PTSD) is a mental disorder characterized by disturbing symptoms that interfere with daily functioning. PTSD symptoms may start very quickly following a traumatic event, or they might not appear for years after the event including intrusive memories or reliving of the experience, avoidance of anything that reminds the person of the trauma, negative changes in thinking or mood that are a result of the trauma and which interfere with daily functioning, and changes in the person’s emotional reactions to everyday events.
The global post-traumatic stress disorder treatment market is majorly driven by an increase in the prevalence of post-traumatic stress disorder due to the increase in the number of accidents or incidents across the globe. In addition, an increase in clinical trials and a rise in the geriatric population drives the growth of the market in upcoming years. However, side effects associated with drug treatment are expected to hamper the market. Moreover, the increase in research & development activities for antidepressant drugs against post-traumatic stress disorder, rise in government initiatives for post-traumatic stress disorder treatment management, and increase in healthcare expenditure in developing countries are the key factor that boosts the growth of the market.
The post-traumatic stress disorder treatment market is segmented on the basis of treatment type, age group, end-user, and region. On the basis of treatment type, the market is divided into drugs and psychotherapy. By drugs, the market is classified into antidepressants, antipsychotics, beta-blockers, benzodiazepines, and others. Psychotherapy, the market is divided into cognitive behavior therapy, psychodynamic therapy, and others. On the basis of age, the market is divided into geriatric, pediatric, and adults. By end-user, the market is classified into hospitals, outpatients’ clinics, mental health centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
.The key players operating in the global post-traumatic stress disorder treatment market are Acadia Healthcare, Behavioral Health Network, Inc., CareTech Holdings Plc, GlaxoSmithKline Plc, Pfizer, Inc, Viatris, Inc, Strategic Behavioral Health, Ascension Seton, North Range Behavioral Health, Pyramid Healthcare and Eily Lilly and Company.
The global post-traumatic stress disorder treatment market is majorly driven by an increase in the prevalence of post-traumatic stress disorder due to the increase in the number of accidents or incidents across the globe. In addition, an increase in clinical trials and a rise in the geriatric population drives the growth of the market in upcoming years. However, side effects associated with drug treatment are expected to hamper the market. Moreover, the increase in research & development activities for antidepressant drugs against post-traumatic stress disorder, rise in government initiatives for post-traumatic stress disorder treatment management, and increase in healthcare expenditure in developing countries are the key factor that boosts the growth of the market.
The post-traumatic stress disorder treatment market is segmented on the basis of treatment type, age group, end-user, and region. On the basis of treatment type, the market is divided into drugs and psychotherapy. By drugs, the market is classified into antidepressants, antipsychotics, beta-blockers, benzodiazepines, and others. Psychotherapy, the market is divided into cognitive behavior therapy, psychodynamic therapy, and others. On the basis of age, the market is divided into geriatric, pediatric, and adults. By end-user, the market is classified into hospitals, outpatients’ clinics, mental health centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
.The key players operating in the global post-traumatic stress disorder treatment market are Acadia Healthcare, Behavioral Health Network, Inc., CareTech Holdings Plc, GlaxoSmithKline Plc, Pfizer, Inc, Viatris, Inc, Strategic Behavioral Health, Ascension Seton, North Range Behavioral Health, Pyramid Healthcare and Eily Lilly and Company.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the post-traumatic stress disorder treatment market analysis from 2021 to 2031 to identify the prevailing post-traumatic stress disorder treatment market opportunities.
- The Market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the post-traumatic disorder treatment market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global post-traumatic stress disorder treatment market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Treatment Type
- Drugs
- Pyschotherapy
By Age Group
- Pediartic
- Geriatric
- Adult
By End User
- Mental Health Center
- Others
- Hospitals
- Outpaitent Clinics
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Spain
- Rest of Europe
- Germany
- France
- U.K.
- Italy
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Acadia Healthcare
- Behavioral Health Network, Inc
- Caretech Holdings PLC
- GlaxoSmithKline Plc
- Pfizer, Inc
- Viatris, Inc
- Strategic Behavioral Health
- North Range Behavioral Health
- Pyramid Healthcare
- Eily Lilly and Company
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET, BY TREATMENT TYPE
CHAPTER 5: POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET, BY AGE GROUP
CHAPTER 6: POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET, BY END USER
CHAPTER 7: POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Post Traumatic Stress Disorder Treatment Market" the Post Traumatic Stress Disorder Treatment Market size was valued at $16.0 billion in 2021, and is estimated to reach $26.1 billion by 2031, growing at a CAGR of 4.9% from 2022 to 2031.Post-traumatic stress disorder (PTSD) is a mental health condition triggered by either experiencing it or witnessing it. Post-traumatic stress disorder treatment help to improve in patient’s thinking power, changes in physical activity & regains a sense of control over life. The mode of treatment applied for post-traumatic stress disorder includes medication, therapies, self-care & nutrition.
Post Traumatic Stress Disorder Treatment Market trends are a rise in the prevalence of violent incidents, accidents, and occupational hazards, an increase in research & development activities for drug therapies, rise in the initiative are taken by the government for post-traumatic stress disorder treatment accelerate the Post Traumatic Stress Disorder Treatment Market growth. Moreover, the increase in demand for post-traumatic stress disorder treatment drugs, and the surge in the number of mental and physical abuse cases across the world are the Post Traumatic Disorder Treatment Market trends that drive the growth of the post-traumatic stress disorder treatment market. However, side effects associated with drugs are expected to hamper the growth of the Post Traumatic Stress Disorder Treatment Market.
COVID-19 Impact
The COVID-19 impact has had a positive impact on the post-traumatic stress disorders due to the surge in product sales for maintaining post-traumatic stress conditions. According to a survey conducted by WHO, about 60% of the high-income countries provided telemedicine and teletherapy consultation to patients with severe symptoms of post-traumatic stress disorder. Pharmaceutical Companies amid the pandemic focused on maintaining a balance between supply and demand thus keeping their drug sale intact. Furthermore, during the pandemic large number of patients witnessed a decline in psychotherapies due to COVID-19 which led to rising in the adoption of drugs and medication intended for the treatment of the post-traumatic disorder treatment market. For instance, in 2020, prescription drugs for stress anxiety and post-traumatic disorder spiked up to 18 % respectively, which lead to the tremendous growth of the market.Post Traumatic Stress Disorder Treatment Market is segmented on the basis of treatment type, age group, end-user, and region. On the basis of treatment type, the market is divided into drugs and psychotherapy. By drugs, the market is classified into antidepressants, antipsychotics, beta-blockers, benzodiazepines, and others. By psychotherapy, the market is divided into cognitive behavior therapy, psychodynamic therapy, and others. On the basis of age, the market is divided into geriatric, pediatric, and adults. By end-user, the market is classified into hospitals, outpatients’ clinics, mental health centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By treatment type, the psychotherapy segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to a rise in the prevalence of post-traumatic stress disorder, and advancements in therapies for post-traumatic stress disorder treatment.
On the basis of age group, the market is classified into children & adults. The adult segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to an increase in the number of road accidents and injuries and an increase in the number of mental and sexual abuse cases among the adults driving the growth of the market.
On the basis of end-user, it is classified into hospitals, outpatient clinics and mental health centers. The hospital segment has the largest Post Traumatic Stress Disorder Treatment Market share in 2021 and is expected to continue this trend during the forecast period, owing to an increase in the number of patients visiting hospitals for post-traumatic stress disorder treatment therapy.
North America accounted for a majority of the global Post Traumatic Stress Disorder Industry share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to its well-established healthcare infrastructure, rise in prevalence of post-traumatic stress disorder, presence of key players, and increase in the volume of medical waste in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to an increase in the prevalence of chronic diseases, a rise in the geriatric population, an increase in demand for healthcare products & services, and rise in a number of hospitals and clinics.
The key players operating in the global post-traumatic stress disorder treatment market are Acadia Healthcare, Behavioral Health Network, Inc., CareTech Holdings Plc, GlaxoSmithKline Plc, Pfizer, Inc, Viatris, Inc, Strategic Behavioral Health, Ascension Seton, North Range Behavioral Health, Pyramid Healthcare and Eily Lilly and Company.
Key Findings of the Study
- By treatment type, the Psychotherapy segment was the highest contributor to the market in 2021.
- By age group, the adult segment was the highest contributor to the market in 2021.
- By end-user, the hospital segment dominated the market in 2021 and is expected to continue this trend during the forecast period.
- By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Acadia Healthcare
- Behavioral Health Network, Inc
- Caretech Holdings plc
- GlaxoSmithKline plc
- Pfizer, Inc
- Viatris, Inc
- Strategic Behavioral Health
- North Range Behavioral Health
- Pyramid Healthcare
- Eily Lilly and Company
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 245 |
| Published | June 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 15976.64 million |
| Forecasted Market Value ( USD | $ 26060.75 million |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
